The global drug delivery solutions market is poised for significant growth, with an estimated value of USD 113.3 million in 2025 and an anticipated compound annual growth rate (CAGR) of 5.8%, reaching USD 199.1 million by 2035. The market’s expansion is driven by the increasing prevalence of chronic diseases and the growing demand for advanced, patient-focused drug delivery systems.